Seeing is believing: eye drops for cataracts

Article

A company in the US, Chakshu Research, claims that it has developed an eye drop that can remove cataracts and restore vision.

A company in the US, Chakshu Research, claims that it has developed an eye drop that can remove cataracts and restore vision.

The company recently completed early clinical trials at several academic centers around the US, including Johns Hopkins University, Harvard University and the University of Utah. It is about to launch Phase II/III trials early next year, and is partnering with researchers at the University of Texas at Galveston.

Its product, tentatively called C-KAD, targets the 50-plus market that is projected to reach $2 billion in annual revenue and possibly more with the rapid aging of the baby boomer demographic.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.